Impacts of new sex- and age-specific TSH and FT4 reference ranges on thyroid status and metabolic disorder associations
Journal of the Endocrine Society · 07.04.2026 · 10 (5)
DOI: 10.1210/jendso/bvag053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 10.03.2026. Verfasst von Sayaka Yamada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi, Gunma 3718511, Jap…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Context
Thyroid hormone levels vary by age, sex, and genetic background; yet most clinical reference ranges (RRs) do not account for these factors, potentially leading to misclassification of thyroid status and missed associations with metabolic disorders.
Objective
The aim of this study was to evaluate the impact of newly established age- and sex-specific reference ranges for thyroid-stimulating hormone (TSH) and free thyroxine (FT4) on the prevalence of thyroid statuses and their associations with metabolic disorders.
Methods
Cross-sectional observational studies were conducted, and we enrolled over 8000 participants who underwent thyroid status evaluation with Abbott and Siemens assay kits. We compared the prevalence of different thyroid statuses and corresponding metabolic disorders based on the new RRs with that based on the manufacturers’ RRs.
Results
New RRs significantly altered the prevalence of several thyroid statuses. Subclinical hypothyroidism increased in middle-aged individuals using Abbott kits but decreased in older individuals using Siemens kits. Syndrome of inappropriate secretion of TSH (SITSH, high FT4 with normal or elevated TSH) increased significantly with both kits when applying the new RRs. SITSH, defined by the new RRs, was significantly associated with increased risks of hypertension (Abbott: odds ratio [OR] 2.00; Siemens: OR 1.70) and diabetes (Abbott: OR 2.65; Siemens: OR 1.68), whereas no such associations were observed using the manufacturers’ RRs.
Conclusion
Age- and sex-specific RRs corrected the misclassification of thyroid status and uncovered a previously underdiagnosed group (SITSH) associated with cardiometabolic risks. These findings support the importance of new RRs for diagnostic accuracy and clinical risk stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Endocrinology and Metabolism, Gunma University Graduate School of Medicine, Maebashi, Gunma 3718511, Japan.
- Hidaka Hospital, Takasaki, Gunma 3700001, Japan.
- Thyroid Federation Japan, Tokyo 1050023, Japan.
ORCID-Profile: Sayaka Yamada, Masanobu Yamada
Zitieren
APA
Yamada, S., Horiguchi, K., Akuzawa, M., Sakamaki, K., Yamada, E., Andou, T., & Yamada, M. (2026). Impacts of new sex- and age-specific TSH and FT4 reference ranges on thyroid status and metabolic disorder associations. Journal of the Endocrine Society, 10(5). https://doi.org/10.1210/jendso/bvag053
Vancouver
Yamada S, Horiguchi K, Akuzawa M, Sakamaki K, Yamada E, Andou T, et al. Impacts of new sex- and age-specific TSH and FT4 reference ranges on thyroid status and metabolic disorder associations. Journal of the Endocrine Society. 2026;10(5). doi:10.1210/jendso/bvag053
BibTeX
@article{Yamada2026,
author = {Yamada, Sayaka and Horiguchi, Kazuhiko and Akuzawa, Masako and Sakamaki, Koji and Yamada, Eijiro and Andou, Tetsuro and Yamada, Masanobu},
title = {Impacts of new sex- and age-specific TSH and FT4 reference ranges on thyroid status and metabolic disorder associations},
journal = {Journal of the Endocrine Society},
year = {2026},
volume = {10},
number = {5},
doi = {10.1210/jendso/bvag053}
}
EUVIMED